Global diabetic kidney disease market is estimated to be valued at USD 3.03 Bn in 2024 and is expected to reach USD 4.21 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.
To learn more about this report, request sample copy
Increasing prevalence of diabetes across the globe is primarily driving the market growth. According to the International Diabetes Federation 2021 Report, approximately 537 million people lived with diabetes in 2021 worldwide and this number is expected to rise to 643 million by 2030 and 783 million by 2045. The market is witnessing significant growth due to rising awareness regarding diabetic kidney disease and availability of various treatment options. Furthermore, developments in areas such as diagnostic tools, drugs, and renal replacement therapies are helping patients in early detection and effective management of the disease. However, high cost of treatment devices and lack of awareness in low-income countries can hamper the market growth during the forecast period.
Rising prevalence of diabetes
Increasing prevalence of diabetes across the globe is primarily driving the market growth. Diabetes has become one of the leading causes of end-stage kidney disease due to both microvascular and macrovascular complications impacting the kidneys over the long run. As more people are diagnosed with diabetes every year due to changing lifestyle habits and lack of physical activity, the risk of developing diabetic kidney disease also increases proportionately. Early detection and treatment can help slow the progression but healthcare systems need to be better prepared to handle this growing caseload.
With improved medical care and living standards, people around the world are living longer. Longer life expectancy means the proportion of elderly population is increasing exponentially in many countries. Age is a significant risk factor for developing chronic kidney diseases including those resulting from diabetes. Older patients typically have longstanding diabetes which increases their vulnerability to kidney damage over the decades. Managing kidney health of the geriatric group is an ongoing challenge. As life expectancy increases globally, more people will live with diabetes into their old age, thus, making them prone to age-related complications like diabetic kidney disease. Healthcare systems need to gear up for the rising healthcare needs of the growing elderly diabetic population at risk of associated co-morbidities.
Diabetic Kidney Disease Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients